Exosome Diagnostics and Therapeutics Research Report 2024: Market to Grow at a Staggering CAGR of 81.2% by 2032


Dublin, Aug. 02, 2024 (GLOBE NEWSWIRE) -- The "Global Exosome Diagnostics and Therapeutics Market by Type (Diagnostics, Therapeutics), Product & Service (Instruments, Kits, Reagents), Source (Stem Cells, Blood, Blood Plasma, Urine), Application (Cancer, Musculoskeletal, CVD) - Forecast to 2032" report has been added to ResearchAndMarkets.com's offering.

The exosome diagnostics and therapeutics market is experiencing rapid growth, with projections indicating a surge from a market size of USD 59 million in 2024 to an impressive USD 6.84 billion by 2032

This remarkable growth trajectory, with a CAGR of 81.2%, is fueled by the increasing number of clinical trials and advancements in exosome-based therapies. These therapies utilize vesicles released by cells to deliver therapeutic payloads effectively across biological barriers, such as the blood-brain barrier.



Despite the significant potential and benefits of exosome therapies, such as enhanced cargo bioavailability, these therapies are on the cusp of regulatory approval. Industry leaders face challenges in standardizing isolation and purification methods, scaling production, and ensuring safety, which are critical for regulatory approval. Key players such as Regeneus Ltd, CUREXSYS, and Direct Biologics LLC are at the vanguard of developing exosome-based therapeutics for various clinical indications.

Advancements in Instrumentation and Service

The instrument and services sector is anticipated to be the fastest-growing segment within the forecast period, driven by the demand for precise exosome characterization and enrichment services. Innovations in flow cytometry, nanoparticle tracking analysis, and ultracentrifugation are expected to underpin market expansion, with industry operators also offering integrated services for scalable exosome manufacturing and comprehensive end-to-end exosome-related services.

Urine Source Segment Leads the Market

In 2023, the urine source segment dominated the exosome diagnostics and therapeutics market. The convenience of non-invasive urine sample collection and the stability of urinary exosomes position them as optimal candidates for early disease detection and diagnosis, particularly pertaining to renal disorders. This is a significant factor driving the market forward.

Cancer Applications to Dominate Exosome Therapeutics

The application of exosomes in cancer therapy stands out, with their role as vectors for therapeutic cargo delivery to target cancer cells. There's a particular focus on deploying exosomes for oncology therapeutics, which is anticipated to be a substantial growth segment for the market.

North America Leads Global Market

North America is expected to maintain its dominance over the global exosome diagnostics and therapeutics market throughout the forecast period. As of April 2024, North America is a key contributor to market revenue, largely due to its early adoption and approval of exosome-based diagnostic products.

This market report underscores the expansive growth of the exosome diagnostics and therapeutics industry and sheds light on the various applications and advancements that are driving the market. With continuous research and development, and a focus on overcoming the present challenges, the exosome diagnostics and therapeutics market is poised for significant expansion in the coming years.

Key Attributes:

Report AttributeDetails
No. of Pages251
Forecast Period2024 - 2032
Estimated Market Value (USD) in 2024$59 Million
Forecasted Market Value (USD) by 2032$6848 Million
Compound Annual Growth Rate81.2%
Regions CoveredGlobal


Companies Featured

  • Bio-Techne
  • NanoFCM Inc.
  • System Biosciences, LLC.
  • Capital Biosciences, Inc.
  • AMSBIO
  • INOVIQ
  • Direct Biologics LLC
  • Regeneus Ltd
  • Curexsys
  • Aegle Therapeutics
  • Mercy BioAnalytics
  • NanoSomiX, Inc.
  • Exonox Biosciences, Inc.
  • Multimmune GmbH
  • Capricor Therapeutics, Inc.
  • Evox Therapeutics
  • ILIAS Biologics Inc.
  • Rion
  • Exogenus Therapeutics
  • EverZom
  • Kimera Labs

For more information about this report visit https://www.researchandmarkets.com/r/k833vk

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

 
Global Exosome Diagnostics and Therapeutics Market

Coordonnées